Mon.Oct 10, 2022

article thumbnail

Five Achievements You Need To Unlock To Become An Antibiotic Ninja

IDStewardship

In this article a pharmacist with specialized training in infectious diseases discusses five key areas of study to master in the field of antimicrobial pharmacotherapy, to become an antibiotic ninja. Authored By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP. Article posted 11 October 2022. It is commonplace for learners such as students and residents to struggle with infectious diseases pharmacotherapy.

255
255
article thumbnail

Follow the Money

Drug Topics

As he prepared to move house, our columnist was struck by the similarities between a yard sale and the prescription drug pricing infrastructure.

198
198
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Which diet and health habits are backed by science? Now there’s a tool for that

STAT

Does eating red meat increase one’s risk of heart disease? Would eating more vegetables help? Is leaving high blood pressure untreated really a death wish? The answers might vary, depending on who a person asks, which friend or TikTok nurse, and when. Researchers at the University of Washington want to make it easier to find current, evidence-based health advice.

141
141
article thumbnail

October 2022: In This Issue

Drug Topics

A look at what’s to come in the October issue of Drug Topics®.

200
200
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Trends in Behavioral and Mental Health Treatment Since the Start of the Pandemic

Pharmacy Times

New research finds that mental health has replaced COVID-19 as the top health concern among Americans, but deeper analysis needs to be done into whether depression and anxiety are truly becoming more widespread.

132
132
article thumbnail

Live Now: Drug Topics® Annual Salary Survey

Drug Topics

Readers, we want to hear from you.

227
227

More Trending

article thumbnail

Spotlight on Mental Health: World Mental Health Day 2022

Drug Topics

Make mental health a priority.

212
212
article thumbnail

FDA Approves Furosemide Injection for Congestion in Patients with Chronic Heart Failure

Pharmacy Times

Furosemide injection 80 mg/10 mL (Furoscix; scPharmaceuticals) is indicated for the at-home treatment of congestion caused by fluid overload in adult patients with New York Heart Association Class II/III chronic heart failure.

FDA 123
article thumbnail

Robotic Capsule Can Help Patients Digest Vancomycin, Insulin

Drug Topics

Technlogy could greatly improve drug absorption.

185
185
article thumbnail

Study: Students at High-Achieving Public Charter School Have Lower Rates of Substance Use Disorder, Better Health Outcomes

Pharmacy Times

Male students admitted into a high-performing public charter school found to have better physical health and lower body mass index than their female counterparts.

123
123
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

A doctor’s humbling journey treating long Covid: ‘The second we think we know what we are doing, we fall flat on our face’

STAT

I first met Wes Ely in 2016, when I wrote about ICU delirium and Ely’s attempts, as a critical-care physician at Vanderbilt University Medical Center, to urge fellow health care workers to rethink the use of heavy sedation in ICUs. His research was an attempt to limit the crippling cognitive and physical impairments he saw develop in many critical-care patients long after they left the hospital, something he came to call post intensive care syndrome, or PICS.

Hospitals 118
article thumbnail

NCPA Appoints a New Director to the NCPA Innovation Center Board of Directors

Pharmacy Times

Jeanine Singer, senior vice president of Field Sales and Operations at McKesson, discusses being appointed to the NCPA Innovation Center Board of Directors.

123
123
article thumbnail

How the food allergy sector is benefitting from health tech’s recent boom

pharmaphorum

For the 32 million individuals in the US with food allergies, more research into symptoms, causes, and treatments has been long sought after, but historically underfunded. The National Institutes of Health (NIH), which oversees disease research, has a total annual budget equivalent to $120 per person, with only $0.19 per person being spent on food allergy research.

article thumbnail

Non-affective Psychotic Disorders Could Increase Risk of Dementia in Younger Patients

Pharmacy Times

New research about the risks of dementia in patients with non-affective psychotic disorders could help shape new life course models for prevention.

123
123
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

The digital therapeutics revolution is happening and Big Pharma is buying in — with caution

PharmaVoice

Companies like Pfizer, Novartis, Sanofi and BMS are diving into the world of digital therapeutics while recognizing the limitations of the young field.

116
116
article thumbnail

Analysis Finds IVIG is a Viable Approach for Autoimmune Neurological Diseases

Pharmacy Times

Intravenous immunoglobulin was more effective than placebo, but not more effective than plasmapheresis and corticosteroids.

131
131
article thumbnail

STAT+: Merck touts positive results on key drug from $11.5 billion Acceleron merger

STAT

Merck said Monday the key drug from its $11.5 billion purchase of the biotech Acceleron met its main goal in a key clinical trial. The medicine, sotatercept, is meant to treat pulmonary arterial hypertension, a disease in which high blood pressure in the arteries of the lungs leads to difficulty breathing and walking. Merck did not disclose detailed results in its press release, but said that the medicine resulted in a “statistically significant and clinically meaningful” increase

105
105
article thumbnail

Pharmacy Focus: Move the Needle Monday- The 2022-23 Flu Season and What to Expect

Pharmacy Times

Keeping up with the latest immunizations and being prepared for this year's flu season is essential to staying on top of your health.

article thumbnail

Opinion: The first malaria vaccine is here. Let’s meet the moment

STAT

One child dies every two minutes from malaria. Wider use of a new vaccine can make a dent in that devastating statistic. The World Health Organization recommends the vaccine for broad use in sub-Saharan Africa and other areas with moderate to high malaria transmission, after years of studies in some 900,000 children showed it to be safe and effective.

Vaccines 101
article thumbnail

Patient insights data

PharmaVoice

While there are many sources of real-world evidence, there’s growing interest and focus on capturing patient generated insights to capture a more specific level of understanding for a given therapy.

98
article thumbnail

STAT+: Second U.S. oncology provider plans to go public

STAT

The U.S. is about to have not just one, but two, standalone publicly-traded oncology providers. Florida-based American Oncology Network, a company with more than 100 affiliated doctors across 18 states, announced last week it plans to go public. The news comes about a year after another large oncology provider chain hit the stock market. Its shares have since lost roughly half their value.

101
101
article thumbnail

How to Practice Self-Care as a Healthcare Worker 

Board Vitals - Pharmacist

You hear it over and over when flying: “When the oxygen masks drop, put your own mask on first, before assisting others.” Why is this such critical advice? Because if you can’t perform it, you can’t help others. The same stands true in life as a healthcare worker. If you don’t take care of yourself and practice well-nurtured types of self-care, you can’t help others.

article thumbnail

A Brief Overview of Loop Diuretics Used in Heart Failure

Pharmacy Times

The combination of loop diuretics with other drugs that act at different pharmacologic targets has been shown to improve diuretic response in patients with heart failure.

91
article thumbnail

Covid: hopes for Oxford nasal vaccine dealt blow after poor trial results

The Guardian - Pharmaceutical Industry

Scientists ditch plans to develop nasal spray version of Oxford/AstraZeneca vaccine in its current form Hopes of distributing the Oxford/AstraZeneca Covid vaccine as a nasal spray have been dealt a blow after researchers said it performed poorly in its first clinical trial. The underwhelming results have led scientists to abandon plans to develop the spray in its current form, with hopes now resting on different formulations of the vaccine and more complex delivery devices, such as nebulisers th

article thumbnail

NFTs: What This New Kid on the Blockchain Means for Healthcare

PharmExec

There has been a push to implement NFTs, or non-fungible tokens, across many verticals, but there is still much to learn about their potential uses in healthcare and its brands.

94
article thumbnail

Opinion: The cost of doing nothing: Congress is missing a rare opportunity to improve FDA policies and help people with deadly illnesses

STAT

Congress has taken the necessary step of including critical reauthorizations for the Prescription Drug User Fee Act in its continuing resolution that will avert a partial government shutdown. Successful reauthorization of the act, which sets the funding structure for the Food and Drug Administration, will ensure that it has the funds to fulfill its vital mission.

FDA 98
article thumbnail

Lenny & Larry’s previews seasonal releases

Drug Store News

Flavors making their return include gingerbread and peppermint chocolate, as well as the holiday collection variety pack, which includes winter and fall seasonal varieties.

93
article thumbnail

STAT+: European Commission says preliminary findings indicate Teva violated antitrust rules

STAT

After three years of probing, the European Commission has reached a preliminary decision that Teva Pharmaceuticals illegally used different strategies to prevent rival companies from introducing versions of a top-selling medicine. The review found that Teva used various patent maneuvers to thwart generic manufacturers from being able to market copycat versions of the Copaxone multiple sclerosis treatment.

Hospitals 100
article thumbnail

Funding boost for CPI’s RNA vaccine innovation centre

European Pharmaceutical Review

The Centre for Process Innovation (CPI) was granted £10.65 million to support its work in development, scale-up and manufacture of RNA therapies and finance the training centre already established at the site, which aims to upskill the future RNA workforce. The RNA Centre of Excellence is the only UK site equipped to develop and manufacture millions of doses of a messenger and self-amplifying RNA vaccines.

article thumbnail

New partnership may give MDMA an edge in the psychedelics space

PharmaVoice

While LSD and psilocybin steal the spotlight, drug developers are also exploring MDMA for a wide swath of neurological illnesses.

104
104
article thumbnail

Rite Aid partners with Google Cloud to enhance customers’ online experience

Drug Store News

With Anthos, Rite Aid’s more than 2,350 pharmacies will have cloud computing capabilities on-site.

115
115
article thumbnail

Drug Shortages Update: October 2022

OctariusRx

This week we are once again providing an update on the most recent drug shortages. Drug shortages currently remain at over 100 different medications, with the Food and Drug Administration (FDA) noting 125 products as being unavailable. Some of these shortages are short term, or limited availability, while others are completely unavailable with unknown release dates.

article thumbnail

OPI enters press-on nail category

Drug Store News

OPI xPress/On consists of 33 press-on gel-like salon manicures that come in 15 of the brand’s iconic shades.

98
article thumbnail

Pharmacist Insights: Descovy and Truvada for HIV Pre-Exposure Prophylaxis

Pharmacy Times

Clinical studies have shown similar efficacy between emtricitabine and tenofovir alafenamide (Descovy) and emtricitabine and tenofovir disoproxil fumarate (Truvada) for individuals at risk for HIV infection.

65